Skip to main content
Signal8

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Form 8-K — May 28, 2026

$BCLIForm 8-KItems 5.02, 7.01, 9.01Filed May 28, 2026, 4:05 PM ET0001104659-26-067474Original filing

Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI) appointed Peter J. Pitts, former Associate Commissioner of the U.S. Food & Drug Administration, to its Board of Directors effective May 25, 2026.

Key figures

Board size increase
7 to 8
Option grant shares
150000

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.